Visit https://www.peervoice.com/KJE860 to view the entire programme with slides. After completing “Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations”, participants will be able to: Describe the rationale for intratumoural administration of oncolytic immunotherapies for skin cancer; Discuss the technical and practical considerations for intratumoural administration of oncolytic immunotherapies; and Identify oncolytic immunotherapies in development for skin cancer.